[Federal Register Volume 61, Number 109 (Wednesday, June 5, 1996)]
[Notices]
[Page 28598]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 96-14057]



-----------------------------------------------------------------------


DEPARTMENT OF JUSTICE

Manufacturer of Controlled Substances; Application

    Pursuant to Sec. 1301.43(a) of Title 21 of the Code of Federal 
Regulations (CFR), this is notice that on April 22, 1996, Penick 
Corporation, 158 Mount Olivet Avenue, Newark, New Jersey 07114, made 
application to the Drug Enforcement Administration (DEA) for 
registration as a bulk manufacturer of the basic classes of controlled 
substances listed below:

------------------------------------------------------------------------
                     Drug                               Schedule        
------------------------------------------------------------------------
Tetrahydrocannabinols (7370).................  I                        
Dihydromorphine (9145).......................  I                        
Pholcodine (9314)............................  I                        
Methylphenidate (1724).......................  II                       
Coca Leaves (9040)...........................  II                       
Cocaine (9041)...............................  II                       
Codeine (9050)...............................  II                       
Dihydrocodeine (9120)........................  II                       
Oxycodone (9143).............................  II                       
Hydromorphone (9150).........................  II                       
Diphenoxylate (9170).........................  II                       
Benzoylecgonine (9180).......................  II                       
Ethylmorphine (9190).........................  II                       
Hydrocodone (9193)...........................  II                       
Meperidine (9230)............................  II                       
Methadone (9250).............................  II                       
Methadone-intermediate (9254)................  II                       
Dextropropoxyphene, bulk (non-dosage forms)    II                       
 (9273).                                                                
Morphine (9300)..............................  II                       
Thebaine (9333)..............................  II                       
Opium, raw (9600)............................  II                       
Opium extracts (9610)........................  II                       
Opium fluid extract (9620)...................  II                       
Opium tincture (9630)........................  II                       
Opium powdered (9639)........................  II                       
Opium granulated (9640)......................  II                       
Levo-alphacetylmethadol (9648)...............  II                       
Opium poppy (9650)...........................  II                       
Oxymorphone (9652)...........................  II                       
Poppy Straw Concentrate (9670)...............  II                       
Alfentanil (9737)............................  II                       
Sufentanil (9740)............................  II                       
Fentanyl (9801)..............................  II                       
------------------------------------------------------------------------

    The firms plans to manufacture the listed controlled substances for 
distribution as bulk pharmaceutical products to its customers.
    Any other such applicant and any person who is presently registered 
with DEA to manufacture such substances may file comments or objections 
to the issuance of the above application.
    Any such comments or objections may be addressed, in quintuplicate, 
to the Deputy Assistant Administrator, Office of Diversion Control, 
Drug Enforcement Administration, United States Department of Justice, 
Washington, DC 20537, Attention: DEA Federal Register Representative 
(CCR), and must be filed no later than August 5, 1996.

    Dated: May 22, 1996.
Gene R. Haislip,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 96-14057 Filed 6-4-96; 8:45 am]
BILLING CODE 4410-09-M